For instance, CD4+ CD25+ Tregs have been shown to suppress inflammation-associated CRC development through the release of IL-10 [56], and induce CRC regression in the Apcmin/+ mouse model of CRC by regulating the homeostasis of epithelial cells [57]. This evidence concerns the gene CD4 and colorectal carcinoma.